Screening for type 2 diabetes: update of 2003 systematic evidence review for the U.S. Preventive Services Task Force.
Norris SL, Kansagara D, Bougatsos C, Nygren P
Record ID 32011001414
English
Authors' objectives:
To examine the evidence of the potential benefits and harms of screening adults for type 2 diabetes mellitus (DM2) and prediabetes in primary care settings in the United States.
Authors' recommendations:
There is no direct trial evidence of the effectiveness of screening for DM2 or prediabetes. Data from the prior US Preventive Services Task Force review lead to recommendations that persons with DM2 with hypertension or hyperlipidemia benefit from screening for DM2; we identified few additional, relevant studies. There is evidence that lifestyle and pharmacotherapy can delay the progression of DM2 among persons with prediabetes, but little direct evidence that identifying persons with prediabetes will lead to longterm health benefits, although longer-term follow-up of these trials has yet to be completed.
Details
Project Status:
Completed
Year Published:
2008
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Diabetes Mellitus, Type 2
- Mass Screening
Contact
Organisation Name:
Agency for Healthcare Research and Quality
Contact Address:
Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name:
martin.erlichman@ahrq.hhs.gov
Contact Email:
martin.erlichman@ahrq.hhs.gov
Copyright:
Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.